ReviewClinical pharmacokinetics2022

Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review.

María Patricia Hernández-Mitre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.